Arcutis Biotherapeutics Inc (ARQT) Stock Price

25.415 ▼ -2.535 (-9.07%)
Open: 27.74 Vol: 2.72M Day's range: 24.95 - 28.12 Feb 20, 16:00 EST
IEX quote, 15 minutes delayed during trading hours. Login or Signup to see real-time data
Free Stock Screener
Loading chart ...
ARQT Technical Analysis
5 mins 30 mins Hourly Daily Weekly
SELL SELL SELL SELL SELL
  5 mins 30 mins Hourly Daily Weekly
MA5 25.30▲ 25.85▼ 25.98▼ 26.51▼ 26.03▼
MA10 25.42▲ 26.38▼ 26.86▼ 26.69▼ 27.02▼
MA20 25.75▼ 27.04▼ 26.95▼ 26.31▼ 26.31▼
MA50 26.25▼ 26.82▼ 26.55▼ 27.53▼ 19.58▲
MA100 26.99▼ 26.61▼ 26.46▼ 25.89▼ 15.11▲
MA200 27.04▼ 26.40▼ 26.53▼ 20.43▲ 14.01▲
  5 mins 30 mins Hourly Daily Weekly
MACD -0.014▼ -0.249▼ -0.255▼ 0.084▲ -0.687▼
RSI 37.052▼ 25.527▼ 30.745▼ 42.335▼ 54.250▲
STOCH 20.331     5.571▼ 15.464▼ 54.099     18.712▼
WILL %R -56.784     -86.129▼ -86.129▼ -74.724     -87.414▼
CCI -40.703     -137.874▼ -173.624▼ -43.920     -80.780    
Latest Filters Detected On ARQT
RSI $ARQT RSI(14) Crossed Below 50 Set Alert
MA $ARQT Price Crossed Below MA(50) Set Alert
MA $ARQT Price Crossed Below MA(26) Set Alert
MA $ARQT Price Crossed Below MA(13) Set Alert
MA $ARQT Price Crossed Below MA(7) Set Alert
▼ BREAK $ARQT Price Breaks 10 Days Low Set Alert
Arcutis Biotherapeutics Inc News
Arcutis Biotherapeutics Touts ZORYVE Expansion, New Indications and 2026 Cash-Flow Breakeven Goal
Wednesday, February 11, 2026 03:26 PM
Executives from Arcutis Biotherapeutics (NASDAQ:ARQT) outlined their commercial priorities for the ZORYVE franchise, discussed potential label-expansion opportunities, and provided updates on pipeline ...
Baron Health Care Fund: Expecting high operating margins for Arcutis Biotherapeutics (ARQT)
Friday, February 06, 2026 05:26 AM
Baron Funds, an investment management company, released its fourth-quarter investor letter for the “Baron Health Care Fund”. A copy of the letter can be downloaded here. The fund rose 13.10% ...
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Thursday, February 05, 2026 08:00 AM
WESTLAKE VILLAGE, Calif., Feb. 05, 2026 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations in ...
ARQT historical stock data
date open high low close volume
20/02/26 27.74 28.12 24.95 25.415 2,716,557
19/02/26 26.59 28.01 26.28 27.95 1,213,237
18/02/26 26.60 27.32 26.53 26.71 1,132,756
17/02/26 25.85 26.665 25.50 26.61 1,177,917
13/02/26 26.85 26.97 25.83 25.86 786,462
12/02/26 26.68 26.76 25.89 26.71 1,099,967
11/02/26 26.91 27.18 25.84 26.59 675,278
10/02/26 26.74 27.2399 26.47 26.88 696,589
09/02/26 27.33 27.62 26.60 26.88 883,734
06/02/26 26.50 27.50 26.405 27.32 1,363,028
Quote Details
52wk Low:11.75
52wk High:31.77
Vol:2.72M
Avg Vol(3m):30.3M
1Y Chng:+76.74%
1M Chng:-14.94%
Add to Watch List
More Information
Index US Composite
Market Cap. 3.42B